SelectQuote, Inc. Reports Fourth Quarter of Fiscal Year 2025 Results
SelectQuote, Inc. has released its financial results for the fourth quarter of fiscal year 2025, showcasing significant growth and improvements in various segments. The company, known for providing unbiased comparisons from multiple insurance companies, has demonstrated robust performance across its core business lines.
Financial Highlights
For the fourth quarter of fiscal year 2025, SelectQuote reported consolidated revenue of $345.1 million, a notable increase from $307.2 million in the same period of the previous year. The company achieved a net income of $12.9 million, a significant turnaround from a net loss of $31.0 million in the fourth quarter of fiscal year 2024. However, consolidated Adjusted EBITDA saw a decline to $2.7 million from $14.4 million in the previous year.
Business and Operational Highlights
The company's performance across its three segments—Senior, Healthcare Services, and Life—was mixed. The Senior segment reported a revenue of $82.5 million and an Adjusted EBITDA of $7.7 million, with 85,344 approved Medicare Advantage policies. The Healthcare Services segment showed strong growth with a revenue of $214.0 million and an Adjusted EBITDA of $11.9 million, driven by an increase in SelectRx members to 108,018. The Life segment also performed well, with a revenue of $48.0 million and an Adjusted EBITDA of $6.9 million.
Strategic Initiatives and Corporate Developments
CEO Tim Danker highlighted the company's holistic healthcare services model, which has been a key driver of value for stakeholders. The company has consistently outperformed its Adjusted EBITDA forecasts by more than 20% each year for the past three years. This success is attributed to the talent and hard work of the company's workforce, as well as its ability to adapt to changes in the Medicare Advantage market.
Management's Perspective
Tim Danker, SelectQuote's Chief Executive Officer, expressed pride in the company's financial results, which exceeded initial expectations for the third consecutive year. He emphasized the company's commitment to providing tailored advice and healthcare solutions that result in better health outcomes for policyholders and patients. Danker also noted that the company's diverse revenue streams are expected to drive increasing cash flow and support new growth initiatives in the future.
Future Outlook
Looking ahead to fiscal year 2026, SelectQuote has provided guidance ranges for revenue and Adjusted EBITDA. The company expects revenue to be in the range of $1.650 billion to $1.750 billion and Adjusted EBITDA to be between $120 million and $150 million. This forward-looking guidance reflects the company's confidence in its growth strategies and market position.
SEC Filing: SelectQuote, Inc. [ SLQT ] - 8-K - Aug. 21, 2025